Burning Rock Biotech (BNR) Non-Current Deffered Revenue (2019 - 2020)
Burning Rock Biotech (BNR) posted quarterly Non-Current Deffered Revenue of $39684.9 for Q4 2020, down 71.78% year-over-year from $140603.8 in Q1 2020, and up 1.76% quarter-over-quarter from $39000.0 in Q3 2020.
Burning Rock Biotech (BNR) Non-Current Deffered Revenue (2019 - 2020) Analysis & Trends
Burning Rock Biotech's Non-Current Deffered Revenue history runs 2 years deep, the most recent figure standing at $39684.9 for Q4 2020.
- In Q4 2020, Non-Current Deffered Revenue fell 71.78% year-over-year to $39684.9; the TTM figure through Dec 2020 stood at $39684.9 (down 71.78% YoY), while the FY2020 annual figure was $40000.0, down 72.13% from the prior year.
- Non-Current Deffered Revenue for Q4 2020 stood at $39684.9, up from $39000.0 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $140603.8 in Q4 2019, with the low at $37000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | - |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 32.59 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | - |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 17.00 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | - |
| 10 | Burning Rock Biotech | 781.17 Mn | 711.04 Mn | 11.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 39,684.94 |
| Sep 30, 2020 | 39,000.00 |
| Jun 30, 2020 | 37,000.00 |
| Dec 31, 2019 | 140,603.84 |